RespireRx Pharmaceuticals Inc (RSPI)

[enemem]

I don't think PIPEs are an option until share-price is a dollar higher, so whatever their motive, they never got the leverage. I certainly don't think they tried to arrange things for an August announcement, but since that's the way things turned out, my guess is that they want to postpone RD1 until after labor day. If that produces a more substantial bounce then they have the PIPE option, but I don't think the market is going to be convinced by the science by itself. There has to be the kind of partnership buzz that Neuro referred to to produce a share-price increase, and with a partnership in hand, it isn't obvious why they would also do a PIPE. So I don't foresee a PIPE.

Of course, if the RD-1 results were to undercut efficacy and/or analgesia preservation, then a PIPE would likely be futile too, since the terms would be so bad.

I think cor has to get a partnership deal. It is the only thing that will restore credibility to this company. Cor has established efficacy for 2 multimillion dollar indications, there are no major safety issues with the low-impacts, and yet the stock is still below a dollar. More science isn't going to change how the market views cor.